Image Quality Testing and Compliance Validation

The contract involves independent verification of detector performance to ensure compliance with key FDA image quality metrics, specifically requiring a modulation transfer function of at least 50% at 1 line pair per millimeter, a detective quantum efficiency of no less than 70% at 0 line pairs per millimeter, and lag not exceeding 3%. These benchmarks must be validated using RQA5 or equivalent standardized testing methodologies to confirm the detector meets regulatory standards for medical imaging systems. The work is scoped as a subcontract under the FDA Office of Acquisition and Grant Services, with performance expected to take place in Silver Spring, Maryland, 20993. The opportunity was posted on May 5, 2026, and responses are due by May 12, 2026, at 2:00 PM Eastern Time. The North American Industry Classification System code 541380 indicates this contract falls under other scientific and technical consulting services, aligning with specialized testing and compliance validation activities. While no set-aside status or point of contact is specified, the contract is managed under the Department of Health and Human Services and requires strict adherence to technical criteria to ensure the detector’s suitability for clinical use under FDA oversight.